Home

BioHarvest Sciences Inc. - Common Stock (BHST)

6.1500
+0.00 (0.00%)
NASDAQ · Last Trade: Apr 3rd, 9:46 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close6.150
Open-
Bid6.050
Ask6.450
Day's RangeN/A - N/A
52 Week Range4.724 - 6.890
Volume111
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & YieldN/A (N/A)
1 Month Average Volume10,624

About BioHarvest Sciences Inc. - Common Stock (BHST)

BioHarvest Sciences Inc. is a biotechnology company focused on the innovative development of natural and sustainable solutions for various industries, including health and wellness, cosmetics, and agriculture. The company specializes in harnessing advanced cellular agriculture technology to cultivate plant-based ingredients with enhanced nutritional and therapeutic properties. By utilizing proprietary methods to grow and produce biomass from living cells, BioHarvest aims to provide high-quality products that are environmentally friendly and offer significant health benefits, thus contributing to healthier lifestyles and more sustainable production practices. Read More

News & Press Releases

BioHarvest Sciences Reports Fourth Quarter and Full Year 2024 Financial Results
Fourth Quarter Revenues Grew 62% to $7.3 Million, Exceeding Prior Management Guidance, with Full Year Revenues Increasing 99% Year-Over-Year to...
Via Newsfile · March 31, 2025
Earnings Scheduled For March 31, 2025benzinga.com
Via Benzinga · March 31, 2025
BioHarvest Sciences to Host Fourth Quarter and Full Year 2024 Earnings Call on March 31 at 4:30 p.m. Eastern Time
Rehovot, Israel--(Newsfile Corp. - March 17, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a...
Via Newsfile · March 17, 2025
BioHarvest Sciences to Participate in 37th Annual Roth Conference on March 16-18, 2025
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 6, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) ("BioHarvest" or the "Company"),...
Via Newsfile · March 6, 2025
BioHarvest In Vitro Testing Shows Proprietary Olive Cell Compound Reduces Fat Accumulation in Liver Cells
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 4, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or...
Via Newsfile · March 4, 2025
EXCLUSIVE: Botanical Synthesis Tech-Focused BioHarvest's First Synthetic Olive Cells Shows Reduced Fat Accumulation in Liver Cellsbenzinga.com
BioHarvest's olive cell compound, rich in Verbascoside, showed promising results in reducing fat accumulation in liver cells, with a 2026 market launch planned.
Via Benzinga · March 4, 2025
BioHarvest Announces Sales of Flagship Product VINIA Now Exceed $50 Million USD
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - February 18, 2025) - BioHarvest Sciences Inc., (NASDAQ: BHST) (FSE: 8MV0)...
Via Newsfile · February 18, 2025
BioHarvest Sciences to Present at WeBull Consumer Stocks Webinar on February 18
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - February 12, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (CSE: BHSC) (FSE:...
Via Newsfile · February 12, 2025
BioHarvest Announces Appointment of Sharon Malka to Board of Directors
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - January 22, 2025) - BioHarvest Sciences Inc., (NASDAQ: BHST) (CSE: BHSC)...
Via Newsfile · January 22, 2025
OTC Markets Group Announces Quarterly Index Performance and Rebalancing
NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated financial markets for 12,000 U.S. and global securities, today announced the fourth quarter 2024 performance and quarterly rebalancing of the OTCQX® and OTCQB® indexes, including the OTCQX Canada Index and the OTCQX Dividend Index.
By OTC Markets · Via GlobeNewswire · January 22, 2025
BioHarvest Issues Shareholder Letter and Provides Corporate Update
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - January 8, 2025) - BioHarvest Sciences Inc., (NASDAQ: BHST) (CSE: BHSC)...
Via Newsfile · January 8, 2025
Tate & Lyle and BioHarvest Announce Partnership to Drive the Future of Ingredients Through Botanical Synthesis Technology
London, United Kingdom and Vancouver, British Columbia--(Newsfile Corp. - December 11, 2024) - Tate & Lyle PLC ('Tate & Lyle'),...
Via Newsfile · December 11, 2024
EXCLUSIVE: BioHarvest Collaborate With Tate & Lyle To Develop Proprietary Plant-Based Moleculesbenzinga.com
Tate & Lyle and BioHarvest Sciences partner to develop sustainable and affordable plant-based molecules for food and beverage industry.
Via Benzinga · December 11, 2024
BioHarvest Sciences Reports Third Quarter 2024 Financial Results
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 25, 2024) - BioHarvest Sciences Inc. (NASDAQ: BHST) (CSE: BHSC) (FSE:...
Via Newsfile · November 25, 2024
BioHarvest Launches VINIA SuperFood Functional Tea Line
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 25, 2024) - BioHarvest Sciences Inc. (NASDAQ: BHST) (CSE: BHSC) (FSE: 8MV0)...
Via Newsfile · November 25, 2024
BioHarvest Sciences to Participate in Noble Capital Markets Emerging Growth Conference on December 3, 2024
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 21, 2024) - BioHarvest Sciences Inc. (NASDAQ: BHST) (CSE: BHSC) (FSE:...
Via Newsfile · November 21, 2024
BioHarvest Sciences to Host Third Quarter 2024 Earnings Call on November 25 at 4:30 P.M. Eastern Time
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 18, 2024) - BioHarvest Sciences Inc. (NASDAQ: BHST) (CSE: BHSC) (FSE: 8MV)...
Via Newsfile · November 18, 2024